← Leaderboards
Loic Pierre Deleyrolle
University Of Florida
$2,367,803
Attributed
$2,367,803
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $652K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,367,803 · 3
By mechanism
R01$1,567,006 · 1
R21$800,797 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Florida
Same institution · by research overlap
- Stephen James Hagen$1,320,814
- Issam Zineh$389,326
- C Keith Ozaki$4,115,723
- Julie E. Johnson$637,515
- Michael J Haller$299,627
Others in their field
Other Emerging Leaders on “Tumor”
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Lynn Briscoe · Leidos Biomedical Research, Inc.$120,794,323
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$105,180,681
- Leonard Freedmand · Leidos Biomedical Research, Inc.$78,762,245
- Connie Suders · Leidos Biomedical Research, Inc.$67,882,919
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
Research focus
TumorCellsReportingT-LymphocyteResistanceBrain NeoplasmsNeoplastic CellPhenotypeImmune SystemTherapy ResistantLaboratoriesIn VivoMalignant NeoplasmsImmuneGliomaCancer TherapyEnvironmentGlioblastomaLinkCellular Metabolic ProcessAerobic GlycolysisIn VitroMetabolicCancer Cell
Grant awards (9)
Metabolic interactions between tumor cells and the immune system in GBM: A potential Achilles heel of GBM for novel therapeutics$366,265
R01 · FY2025 · NS · contact PI
Metabolic interactions between tumor cells and the immunce system in GBM A potential Achilles heel of GBM for novel therapeutics$360,522
R01 · FY2024 · NS · contact PI
Optimizing CAR T therapy via metabolic engineering for thetreatment of GBM$203,187
R21 · FY2024 · CA · contact PI
Optimizing CAR T therapy via metabolic engineering for thetreatment of GBM$1
R21 · FY2024 · CA · contact PI
Metabolic interactions between tumor cells and the immunce system in GBM A potential Achilles heel of GBM for novel therapeutics$416,964
R01 · FY2023 · NS · contact PI
Optimizing CAR T therapy via metabolic engineering for thetreatment of GBM$178,234
R21 · FY2023 · CA · contact PI
Metabolic interactions between tumor cells and the immunce system in GBM A potential Achilles heel of GBM for novel therapeutics$423,255
R01 · FY2022 · NS · contact PI
Slow cycling cell RNA based T cell therapy to prevent recurrence in GBM$228,750
R21 · FY2022 · NS · contact PI
Slow cycling cell RNA based T cell therapy to prevent recurrence in GBM$190,625
R21 · FY2021 · NS · contact PI